BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
72 | 256.00 | 267.20 | 1 |
1 | 250.60 | 269.00 | 100 |
1 | 244.50 | 270.00 | 33 |
49 | 244.30 | 272.00 | 170 |
125 | 242.90 | 274.25 | 5 |
0 | Total | Total | 0 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
72 | 256.00 | 267.20 | 1 |
1 | 250.60 | 269.00 | 100 |
1 | 244.50 | 270.00 | 33 |
49 | 244.30 | 272.00 | 170 |
125 | 242.90 | 274.25 | 5 |
0 | Total | Total | 0 |
Open | 261.80 |
Previous Close | 260.08 |
Volume | 22,484.00 |
Value (Lacs) | 57.81 |
VWAP | 261.38 |
Beta | |
Mkt Cap (Rs. Cr.) | 257 |
High | 269.88 |
Low | 255.00 |
UC Limit | 312.09 |
LC Limit | 208.06 |
52 Week High | 447.50 |
52 Week Low | 203.62 |
Face Value | 10.00 |
All Time High | 2,315.00 |
All Time Low | 203.62 |
20D Avg Volume | 58,650 |
20D Avg Delivery(%) | 14.13 |
Book Value Per Share | 194.30 |
Dividend Yield | 0.00 |
TTM EPS See historical trend | 0.00 |
TTM PE See historical trend | -- (Low PE) |
P/B See historical trend | 1.33 (Low P/B) |
Sector PE | 53.44 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
3 out of 5 years Nureca has given positive returns in September.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
September | 23.55% (2024) | 11.48% | -11.12% (2022) | -7.33% | 3.96% |
Nureca Standalone June 2025 Net Sales at Rs 34.32 crore, up 47.24% Y-o-Y Jul 16 2025 09:14 AM
Nureca Consolidated March 2025 Net Sales at Rs 31.74 crore, up 87.04% Y-o-Y May 06 2025 11:41 AM
Nureca Standalone March 2025 Net Sales at Rs 31.75 crore, up 62.3% Y-o-Y May 06 2025 10:50 AM
Stocks to Watch Today: HUL, Coal India, Gandhar Oil Refinery, Nureca, Paytm, HG Infra, Tata Power, Anant Raj in focus on 22 April Apr 22 2025 01:28 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 116711 | Price 401.94 | % Traded 1.15 |
Qty 63937 | Price 409.84 | % Traded 0.64 |
Qty 63937 | Price 409.49 | % Traded 0.64 |
Qty 65679 | Price 363.99 | % Traded 0.64 |
Qty 51679 | Price 360.28 | % Traded 0.50 |
Qty 158000 | Price 358.81 | % Traded 1.49 |
Qty 95867 | Price 362.41 | % Traded 0.91 |
Qty 95867 | Price 362.11 | % Traded 0.91 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Nureca | 257.10 | -1.15 | 257.10 | - | 1.33 | -0.34 | -24.85 | 0 | 114 | 0.01 |
Poly Medicure | 2,041.80 | 0.43 | 20,688.68 | 57.86 | 7.98 | 12.24 | -20.57 | 333 | 1,669 | 0.06 |
Indegene | 561.40 | 3.26 | 13,478.05 | 69.48 | 7.60 | 9.60 | -7.79 | 181 | 1,093 | 0.00 |
AARTIPHARM | 882.65 | 0.16 | 8,000.45 | 30.02 | 4.31 | 13.68 | 27.77 | 272 | 2,115 | 0.20 |
Prevest Denpro | 583.90 | 2.05 | 700.86 | 36.54 | 7.31 | 17.23 | -4.54 | 18 | 63 | 0.00 |